Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:21 AM
Ignite Modification Date:
2025-12-25 @ 3:21 AM
NCT ID:
NCT00000705
Eligibility Criteria:
Inclusion Criteria
You may be eligible for this study if you:
* Are HIV-positive.
* Have a bleeding disorder such as hemophilia A or B, a lack of factor VIII (a blood clotting factor), or severe von Willebrand's disease.
* Will be available for follow-up for at least a year.
* Are at least 12 years old (consent of parent or guardian required if under 18).
* Are willing to use an effective method of birth control during the study.
Exclusion Criteria
You will not be eligible for this study if you:
* Have a life-threatening opportunistic (AIDS-related) infection or AIDS-related symptoms.
* Have taken certain drugs within 30 days prior to study entry including chemotherapy and interferon.
* Are taking acetaminophen or drugs containing acetaminophen.
* Are pregnant or breast-feeding.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
12 Years
Study:
NCT00000705
Study Brief:
Protocol Section:
NCT00000705